Abstract
This study aimed to prepare a series of novel heterocyclic compounds via the Schiff-Bass cycloaddition reaction of 4-((5-mercapto-1,3,4-thiadiazol-2-yl) imino)methyl)-2-nitrophenol. Schiff bases were used in the synthesis to produce novel Schiff base derivatives, including quinazoline, thiazine, oxazepine, imidazolidine, and tetrazole derivatives. The structures of the derivatives were determined by Fourier transform infrared spectroscopy, 1H NMR, and 13C NMR, and they were evaluated in vitro as antimicrobial and anticancer agents, with several exhibiting useful biological activity. All derivatives were evaluated in vitro for their antimicrobial activity. The new derivatives were studied in vitro against two bacterial species (Escherichia coli and Staphylococcus aureus). The results of the antimicrobial activity study showed encouraging antibacterial activity, with good inhibition rates for some of the studied derivatives compared to the antibiotic amoxicillin. An in vitro study of the product was conducted on the SKGT4 cell line (cancer cells). Cytotoxicity tests showed encouraging results for some of these targeted derivatives against the SKGT4 cell line, with low IC50 values. Theoretically, using a molecular docking program to study the targeted derivative, the cytotoxicity test results were confirmed. The results showed a good low binding energy compared to crizotinib.
Keywords
thiazine. Quinazoline . imidazole . tetrazol . molecular docking esophageal cancer